The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Usefulness of an S-1 dosage formula: An exploratory analysis of randomized clinical trial (JCOG1001).
 
Takeshi Kawakami
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hirofumi Yasui
No Relationships to Disclose
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Hiroko Hasegawa
No Relationships to Disclose
 
Hiroshi Imazeki
No Relationships to Disclose
 
Kazuki Kano
No Relationships to Disclose
 
Yuya Sato
No Relationships to Disclose
 
Satoru Iwasa
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Seagen (Inst); Zymeworks (Inst)
 
Shuji Takiguchi
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; MC Medical; Medtronic; Nippon Kayaku; Olympus; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Intuitive Surgical (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Yuichiro Doki
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; MSD; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Takaki Yoshikawa
Honoraria - AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Johnson & Johnson/Janssen; Medtronic; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)